Regenerate Cells for Longevity True anti-aging is about more than just skin deep
Clinical trial results for retatrutide have exceeded even the high expectations set by tirzepatide, with Phase 2 data published in the New England Journal of Medicine in 2023 demonstrating weight loss approaching 24-25% of baseline body weight over 48 weeks in some dose groups - weight reductions comparable to those achieved with bariatric surgery and substantially exceeding pharmacological obesity treatments available just a few years ago
Our blog delves into the unique challenges, from regulatory hurdles to patient recruitment, and how our comprehensive solutions can help bring these vital therapies to patients faster
C., Ganti, A., Carrier, B., Yan, J., Taeswuan, S., Cohen, V
Weekly weight taken at the same time of day after voiding